Safety Study of PI-0824 to Treat Pemphigus Vulgaris
Completed · Phase 1
Conditions studied: Pemphigus Vulgaris
In brief
The purpose of this study is to determine if the use of PI-0824 in patients with Pemphigus vulgaris is safe.
Key facts
- Study ID
- NCT00063752
- Run by
- Peptimmune
- People needed
- 15
- Starts
- 2003-07-01
- Expected to finish
- 2005-03-01
- Last updated by the study team
- 2005-06-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California San Francisco — San Francisco, California, United States
- Johns Hopkins School of Medicine — Baltimore, Maryland, United States
- East Coast Clinical Research — Salisbury, Massachusetts, United States
- Stony Brook Dermatology Associates — East Setauket, New York, United States
- Long Island Jewish Medical Center — New Hyde Park, New York, United States
- NYU School of Medicine — New York, New York, United States
- Case Western Reserve University — Cleveland, Ohio, United States
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.